Oncology R&D: the patient insights we’re still missing, and how to catch up
pharmaphorum
JULY 26, 2021
Healthcare systems and patients are suffering the consequences, as drug prices and times to market increase, and access to treatments is consequently hindered in the context of an ageing population carrying an ever-rising chronic disease burden. Indeed, increasing costs pose pharma’s biggest R&D challenge today.
52 
Let's personalize your content